Published Date: 22 Dec 2023
Half of the participants in a small trial experienced an early remission of depression symptoms following psilocybin-assisted therapy.
Read Full NewsExplore the evolving landscape of developmental and epileptic encephalopathies in adults, highlighting precision therapies and the need for accurate diagnoses.
Explore the transformative buzzwords in neurology for 2025, highlighting advancements in AI, gene therapy, personalized treatment, and neuroplasticity.
1.
Admissions, medical colleges, fees, and eligibility requirements information for the DNB Post Diploma in Radiation Oncology.
2.
Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC
3.
Brain cancer: a Q&A session.
4.
For older patients with Hodgkin lymphoma, novel regimens produce high response rates.
5.
For MDS-Related Anemia, Telomerase Inhibitor Approved.
1.
Unleashing the Oncolytic Arsenal: Talimogene Laherparepvec Monotherapy – A Targeted Cancer Immunotherapy Treatment
2.
Biomimetic Nanovesicles Target Senescent-Escape Cancer Stem Cells in Breast Cancer
3.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
4.
Exploring the Mysteries of Myxoma: A New Frontier in Medical Research
5.
The Danger of Rectus Sheath Hematoma: A Hidden Risk of Abdominal Surgery
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II
4.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation